Copper-Based Nanoparticles for Effective Treatment Against Sepsis-Induced Lung Injury in Mice Model
Jie-Mei Li,Lu Zhang,Sheng-Lin Pei,Liang Guo,Hong-Lei Shen,Jing He,You-Yuan Guo,Wei-Qing Zhang,Fei Lin
DOI: https://doi.org/10.2147/ijn.s488357
IF: 7.033
2024-12-18
International Journal of Nanomedicine
Abstract:Jie-Mei Li, 1, 2, &ast Lu Zhang, 1, 2, &ast Sheng-Lin Pei, 1, 3 Liang Guo, 1, 3 Hong-Lei Shen, 1, 2 Jing He, 1, 2 You-Yuan Guo, 1, 2 Wei-Qing Zhang, 4 Fei Lin 1, 2 1 Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China; 2 Guangxi Health Commission Key Laboratory of Basic Science and Prevention of Perioperative Organ Disfunction, Nanning, Guangxi, People's Republic of China; 3 Guangxi Clinical Research Center for Anesthesiology, Nanning, Guangxi, People's Republic of China; 4 Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Lin, Department of Anesthesiology, Guangxi Medical University Cancer Hospital, No. 71 hedi Road, Nanning, Guangxi, 530021, People's Republic of China, Tel +8613707886172, Fax +0086-771-536412, Email Wei-Qing Zhang, Department of Experimental Research, Guangxi Medical University Cancer Hospital, No. 71 hedi Road, Nanning, Guangxi, 530021, People's Republic of China, Email Introduction: Lung injury, a common complication of sepsis, arises from elevated reactive oxygen species (ROS), mitochondrial dysfunction, and cell death driven by inflammation. In this study, a novel class of ultrasmall nanoparticles (Cu 4.5 O USNPs) was developed to address sepsis-induced lung injury (SILI). Methods: The synthesized nanoparticles were thoroughly characterized to assess their properties. In vitro experiments were conducted to determine the biologically effective concentration and elucidate the anti-inflammatory mechanism of action. These findings were further supported by in vivo studies, showcasing the material's efficacy in mitigating SILI. Results: The Cu 4.5 O USNPs demonstrated remarkable scavenging capabilities for hydrogen peroxide (H 2 O 2 ), superoxide anions (O 2 − ), and hydroxyl radicals (·OH), attributed to their catalase (CAT)- and superoxide dismutase (SOD)-like activities. Additionally, the nanoparticles exhibited strong anti-inflammatory effects, preserved mitochondrial homeostasis through potent ROS scavenging, and significantly reduced cell death. In vivo studies on mice further validated their protective role against SILI. The conclusion: This study highlights the therapeutic potential of Cu 4.5 O USNPs in treating sepsis-induced lung injury by effectively scavenging ROS and reducing cell death. These findings provide compelling evidence for the future use of copper-based nanoparticles as antioxidant therapeutics. Keywords: ultrasmall copper-based nanoparticles, mitochondria, reactive oxygen species scavenging, lung injury, anti-inflammation Graphical Severe sepsis can lead to multiorgan dysfunction, posing a life-threatening condition and imposing a significant global healthcare burden. 1–3 The lungs are particularly vulnerable in sepsis, significantly increasing mortality risk. 4–7 The pathogenesis of sepsis-induced lung injury (SILI) is closely tied to excessive production of reactive oxygen species (ROS), which upregulate proinflammatory cytokines and trigger an intense inflammatory response in pulmonary tissue. 8–11 Additionally, mitochondrial dysfunction, a key consequence of ROS overproduction, leads to reduced intracellular ATP levels, severely impairing cells' ability to maintain normal physiological activities. 12,13 Previous studies have shown that various forms of programmed cell death, often occurring simultaneously, are associated with mitochondrial dysfunction in conditions such as cerebral ischemia/reperfusion injury and glaucoma. 14–16 Therefore, finding effective strategies to protect mitochondria from ROS-induced damage is crucial. Nanomaterials offer distinct advantages, including biocompatibility, high targeting capabilities, and low toxicity, 17 making them innovative tools for scavenging ROS and addressing ROS-related diseases. Among them, mixtures of cuprous oxide (Cu 2 O) and copper nanoparticles (Cu) have shown strong catalytic activity and ultrasmall dimensions, making them widely used as antioxidants. 18–21 Moreover, ultrasmall Cu-based nanoparticles can be synthesized in an eco-friendly manner, demonstrating superior long-term safety and stability compared to traditional bioenzymes, 22–24 making them promising candidates for therapeutic applica -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology